Apiject has added product development capabilities, including Proof-of-Concept studies that use as little as 8 liters of vaccine or drug product to test compatibility in Blow-Fill-Seal (BFS) using ApiJect prefilled injector technology. Higher volumes may be needed based on the specific requirements of the drug product.
March 1, 2024
Test Drive Our Technology
Might interest you
View All Global Health
Enhancing Distributed Manufacturing and Vaccine Distribution through Blow-Fill-Seal Prefilled Drug Delivery Platforms, Upcoming Webinar Hosted by Xtalks
Adds BFS platform technology to provide large-scale production capacity for sterile drug dosage forms, including injectables, ophthalmics and inhalation Expands Amneal’s extensive domestic pharmaceutical manufacturing footprint News provided by Xtalks l Feb 10, 2025, 08:30 ET In this free webinar, learn about...
Prefilled Apiject Injector
Transitioning your Drug Product or Vaccine into a Prefilled BFS Delivery Device
• Develop an understanding of the technical factors involved in transitioning your drug product, including material compatibility, process parameters, and their effects on drug stability and integrity. • Identify and resolve potential issues by utilizing prototyping and feasibility studies to ensure the...
BFS Technology
The Blow-Fill-Seal Process
The Blow-Fill-Seal (BFS) process is a widely used manufacturing technique in the pharmaceutical industry. It involves the simultaneous formation, filling, and sealing of containers, all within a single machine. This seamless and efficient process ensures the integrity and sterility of the final...